IBD Qorus™, the Foundation’s flagship quality of care program, is designed to drive improved care and health outcomes for patients living with IBD. This first-ever adult IBD learning health system leverages the power of a collaborative improvement network. It brings together providers and patients across the United States to focus on improving how care is delivered in order to produce outcomes-driven results.
Patient-Physician Partnership for Co-Production of Care
Participating patients and their providers share health information (patient-reported outcomes and clinical data) at each visit, and through this process, address those outcomes that are most important to the patient and the provider. Engaging patients in the management of their own care is essential to catalyzing change and improving health outcomes.
Focus on Outcomes Improvement and Value
Health outcomes are important indicators of improvement. Care teams in the Qorus community collaboratively develop and implement quality improvement activities to address specific disparities and gaps in care that lead to suboptimal patient outcomes and, consequently, lower overall value.
Sharing Knowledge and Disseminating Results
Data aggregated from participating sites is used to identify variations in practices and outcomes. These variations are targeted for process improvements that are tested in clinical practice. Care processes that consistently demonstrate prolonged higher quality care and improved outcomes are then adopted by the larger Qorus community to result in greater value in healthcare management.
These characteristics make IBD Qorus a quality-driven and care-focused initiative that will improve care and outcomes for hundreds of thousands of IBD patients. The impact of this program has the potential to reform and advance the way in which all stakeholders within the healthcare system interact to produce care, ultimately leading to optimal health outcomes.
Data can be used for:
- Patient stratification (clinical)
- Clinical trial study feasibility and site selection
- Comparative effectiveness research
Study Lead Co-Principal Investigators
- Corey Siegel, MD -- Dartmouth-Hitchcock Medical Center, Lebanon, NH
- Gil Melmed, MD, MS -- Cedars-Sinai Medical Center, Los Angeles, CA
Currently there are 30 sites participating in IBD Qorus. Over the next three years, the Foundation will significantly expand the number of sites and patients engaged in the program.
For more information, contact Alandra Weaver